Angela Cenci - Publications

Affiliations: 
Basal Ganglia Pathophysiology Unit, Experimental Medical Science, Lund University 
Area:
Parkinson's disease, L-DOPA induced dyskinesia

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, Cenci MA, Svenningsson P, Greengard P, Kaplitt MG. Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787858 DOI: 10.1073/pnas.1524387113  0.8
2016 Carta M, Cenci MA. On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 149. PMID 26749366 DOI: 10.1002/mds.26519  0.8
2015 Shen W, Plotkin JL, Francardo V, Ko WK, Xie Z, Li Q, Fieblinger T, Wess J, Neubig RR, Lindsley CW, Conn PJ, Greengard P, Bezard E, Cenci MA, Surmeier DJ. M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia. Neuron. 88: 762-773. PMID 26590347 DOI: 10.1016/j.neuron.2015.10.039  0.8
2015 Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG, Serrano GE, van Westen D, Londos E, Cenci MA, Hansson O. Increased CSF biomarkers of angiogenesis in Parkinson disease. Neurology. PMID 26511451 DOI: 10.1212/WNL.0000000000002151  0.8
2015 Cenci MA, Francardo V, O'Sullivan SS, Lindgren HS. Rodent models of impulsive-compulsive behaviors in Parkinson's disease: How far have we reached? Neurobiology of Disease. 82: 561-73. PMID 26325219 DOI: 10.1016/j.nbd.2015.08.026  0.8
2015 Nguyen HH, Cenci MA. Preface by the editors. Current Topics in Behavioral Neurosciences. 22: v-viii. PMID 26317142  0.8
2015 Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/j.pneurobio.2015.07.002  0.72
2015 Iderberg H, Maslava N, Thompson AD, Bubser M, Niswender CM, Hopkins CR, Lindsley CW, Conn PJ, Jones CK, Cenci MA. Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Neuropharmacology. 95: 121-9. PMID 25749357 DOI: 10.1016/j.neuropharm.2015.02.023  0.8
2014 Fieblinger T, Graves SM, Sebel LE, Alcacer C, Plotkin JL, Gertler TS, Chan CS, Heiman M, Greengard P, Cenci MA, Surmeier DJ. Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nature Communications. 5: 5316. PMID 25360704 DOI: 10.1038/ncomms6316  0.8
2014 Heiman M, Heilbut A, Francardo V, Kulicke R, Fenster RJ, Kolaczyk ED, Mesirov JP, Surmeier DJ, Cenci MA, Greengard P. Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proceedings of the National Academy of Sciences of the United States of America. 111: 4578-83. PMID 24599591 DOI: 10.1073/pnas.1401819111  0.8
2013 Rylander D, Bagetta V, Pendolino V, Zianni E, Grealish S, Gardoni F, Di Luca M, Calabresi P, Cenci MA, Picconi B. Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 110: E4375-84. PMID 24170862 DOI: 10.1073/pnas.1311187110  0.8
2012 Lindgren N, Francardo V, Quintino L, Lundberg C, Cenci MA. A model of GDNF gene therapy in mice with 6-Hydroxydopamine lesions: time course of Neurorestorative effects and ERK1/2 activation. Journal of Parkinson's Disease. 2: 333-48. PMID 23938263 DOI: 10.3233/JPD-012146  0.8
2012 Halje P, Tamtè M, Richter U, Mohammed M, Cenci MA, Petersson P. Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 16541-51. PMID 23175810 DOI: 10.1523/JNEUROSCI.3047-12.2012  0.8
2012 Mela F, Marti M, Bido S, Cenci MA, Morari M. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels. Neurobiology of Disease. 45: 573-82. PMID 22001605 DOI: 10.1016/j.nbd.2011.09.015  0.8
2011 Ohlin KE, Francardo V, Lindgren HS, Sillivan SE, O'Sullivan SS, Luksik AS, Vassoler FM, Lees AJ, Konradi C, Cenci MA. Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia. Brain : a Journal of Neurology. 134: 2339-57. PMID 21771855 DOI: 10.1093/brain/awr165  0.8
2011 Burguillos MA, Hajji N, Englund E, Persson A, Cenci AM, Machado A, Cano J, Joseph B, Venero JL. Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson's disease patients. Neurobiology of Disease. 41: 177-88. PMID 20850531 DOI: 10.1016/j.nbd.2010.09.005  0.44
2010 Fasano S, Bezard E, D'Antoni A, Francardo V, Indrigo M, Qin L, Doveró S, Cerovic M, Cenci MA, Brambilla R. Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia. Proceedings of the National Academy of Sciences of the United States of America. 107: 21824-9. PMID 21115823 DOI: 10.1073/pnas.1012071107  0.8
2010 Björklund A, Cenci MA. Recent Advances in Parkinson’s disease - translational and clinical research. Progress in Brain Research. 184: vii-viii. PMID 20887866 DOI: 10.1016/S0079-6123(10)84021-X  0.8
2010 Rylander D, Parent M, O'Sullivan SS, Dovero S, Lees AJ, Bezard E, Descarries L, Cenci MA. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Annals of Neurology. 68: 619-28. PMID 20882603 DOI: 10.1002/ana.22097  0.8
2010 Cenci MA, Konradi C. Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Progress in Brain Research. 183: 209-33. PMID 20696322 DOI: 10.1016/S0079-6123(10)83011-0  0.8
2010 Björklund A, Cenci MA. Recent advances in Parkinson's disease: basic research. Preface. Progress in Brain Research. 183: ix-x. PMID 20696311 DOI: 10.1016/S0079-6123(10)83018-3  0.8
2010 Malmlöf T, Rylander D, Alken RG, Schneider F, Svensson TH, Cenci MA, Schilström B. Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias. Experimental Neurology. 225: 408-15. PMID 20659451 DOI: 10.1016/j.expneurol.2010.07.018  0.8
2010 Kobylecki C, Cenci MA, Crossman AR, Ravenscroft P. Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease. Journal of Neurochemistry. 114: 499-511. PMID 20456008 DOI: 10.1111/j.1471-4159.2010.06776.x  0.8
2010 Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Baishen R, Danysz W, Bezard E, Cenci MA. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiology of Disease. 39: 352-61. PMID 20452425 DOI: 10.1016/j.nbd.2010.05.001  0.8
2009 Lane EL, Brundin P, Cenci MA. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Neurobiology of Disease. 35: 42-51. PMID 19361557 DOI: 10.1016/j.nbd.2009.03.014  0.8
2009 Lundblad M, af Bjerkén S, Cenci MA, Pomerleau F, Gerhardt GA, Strömberg I. Chronic intermittent L-DOPA treatment induces changes in dopamine release. Journal of Neurochemistry. 108: 998-1008. PMID 19196428 DOI: 10.1111/j.1471-4159.2008.05848.x  0.8
2009 Schuster S, Doudnikoff E, Rylander D, Berthet A, Aubert I, Ittrich C, Bloch B, Cenci MA, Surmeier DJ, Hengerer B, Bezard E. Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biological Psychiatry. 65: 518-26. PMID 18947822 DOI: 10.1016/j.biopsych.2008.09.008  0.8
2008 Picconi B, Paillé V, Ghiglieri V, Bagetta V, Barone I, Lindgren HS, Bernardi G, Angela Cenci M, Calabresi P. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiology of Disease. 29: 327-35. PMID 17997101 DOI: 10.1016/j.nbd.2007.10.001  0.56
2007 Cenci MA, Lundblad M. Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.25. PMID 18428668 DOI: 10.1002/0471142301.ns0925s41  0.8
2007 Westin JE, Vercammen L, Strome EM, Konradi C, Cenci MA. Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biological Psychiatry. 62: 800-10. PMID 17662258 DOI: 10.1016/j.biopsych.2006.11.032  0.8
2007 Stefanova N, Köllensperger M, Hainzer M, Cenci A, Poewe W, Wenning GK. High dose levodopa therapy is not toxic in multiple system atrophy: experimental evidence. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 969-73. PMID 17427936 DOI: 10.1002/mds.21468  0.44
2007 Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. Journal of Neurochemistry. 101: 483-97. PMID 17359492 DOI: 10.1111/j.1471-4159.2007.04456.x  0.8
2007 Dekundy A, Lundblad M, Danysz W, Cenci MA. Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model. Behavioural Brain Research. 179: 76-89. PMID 17306893 DOI: 10.1016/j.bbr.2007.01.013  0.8
2007 Lindgren HS, Rylander D, Ohlin KE, Lundblad M, Cenci MA. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration. Behavioural Brain Research. 177: 150-9. PMID 17157933 DOI: 10.1016/j.bbr.2006.09.019  0.8
2006 Westin JE, Lindgren HS, Gardi J, Nyengaard JR, Brundin P, Mohapel P, Cenci MA. Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9448-61. PMID 16971529 DOI: 10.1523/JNEUROSCI.0944-06.2006  0.8
2006 Cenci MA, Lundblad M. Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia. Journal of Neurochemistry. 99: 381-92. PMID 16942598 DOI: 10.1111/j.1471-4159.2006.04124.x  0.8
2006 Brundin P, Angela Cenci M, Wieloch T. On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease. Experimental Neurology. 201: 1-6. PMID 16806183 DOI: 10.1016/j.expneurol.2006.04.009  0.72
2006 Carlsson T, Winkler C, Lundblad M, Cenci MA, Björklund A, Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiology of Disease. 21: 657-68. PMID 16256359 DOI: 10.1016/j.nbd.2005.09.008  0.8
2005 Carlsson T, Winkler C, Burger C, Muzyczka N, Mandel RJ, Cenci A, Björklund A, Kirik D. Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. Brain : a Journal of Neurology. 128: 559-69. PMID 15659429 DOI: 10.1093/brain/awh374  0.8
2004 Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiology of Disease. 17: 219-36. PMID 15474360 DOI: 10.1016/j.nbd.2004.07.005  0.8
2004 Picconi B, Gardoni F, Centonze D, Mauceri D, Cenci MA, Bernardi G, Calabresi P, Di Luca M. Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5283-91. PMID 15190099 DOI: 10.1523/JNEUROSCI.1224-04.2004  0.8
2003 Picconi B, Centonze D, HÃ¥kansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neuroscience. 6: 501-6. PMID 12665799 DOI: 10.1038/nn1040  0.8
2002 Winkler C, Kirik D, Björklund A, Cenci MA. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiology of Disease. 10: 165-86. PMID 12127155 DOI: 10.1006/nbdi.2002.0499  0.8
2002 Cenci MA, Whishaw IQ, Schallert T. Animal models of neurological deficits: how relevant is the rat? Nature Reviews. Neuroscience. 3: 574-9. PMID 12094213 DOI: 10.1038/nrn877  0.8
2002 Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. The European Journal of Neuroscience. 15: 120-32. PMID 11860512 DOI: 10.1046/j.0953-816x.2001.01843.x  0.8
1992 Cenci MA, Campbell K, Wictorin K, Björklund A. Striatal c-fos Induction by Cocaine or Apomorphine Occurs Preferentially in Output Neurons Projecting to the Substantia Nigra in the Rat. The European Journal of Neuroscience. 4: 376-380. PMID 12106364  0.8
1991 Kalén P, Cenci MA, Lindvall O, Björklund A. Host Brain Regulation of Fetal Locus Coeruleus Neurons Grafted to the Hippocampus in 6-Hydroxydopamine-Treated Rats. An Intracerebral Microdialysis Study. The European Journal of Neuroscience. 3: 905-918. PMID 12106457  0.8
Show low-probability matches.